GBI Research’s new report, “The Future of Orthopedic Implants, Analysis and Forecasts to 2016 - Joint Reconstruction and Spinal Implants Creating Growth Opportunities” provides key data, information and analysis on the global orthopedic implants market. The report provides market landscape, competitive landscape and market trends information on three orthopedic implants market categories – joint reconstruction, spinal surgery, and trauma fixation. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Global Orthopedic Implants market set to boom in the next seven years driven by ageing population

The global orthopedic implants market is forecast to grow to $41.8 billion by 2016 at the Compounded Annual Growth Rate (CAGR) rate of 7.8% during 2009–2016. Joint reconstruction will remain the largest orthopedic implants category, which is expected to grow at 7.4% CAGR during 2009–2016 to reach $22.9 billion. The spinal surgery category is expected to grow steadily at 10.2% during 2009–2016, to reach $11.3 billion by 2016. The trauma fixation category is expected to grow to $7.7 billion at a CAGR of 6.0% during 2009–2016.

The market will be driven by the aging population, technological advancements in implant designs and materials which are resulting in improved durability and younger patients undergoing surgery in the future.

Growing Incidence of Age Related Orthopedic Indications Such As Osteoarthritis, Spinal Disorders and Osteoporosis to Drive Procedure Volumes

Musculoskeletal problems are strongly associated with age. As the body ages, the bones and muscle tissue start degenerating, thus giving rise to various indications manifested by pain in joints and the back. These problems are especially acute for developing countries, where the percentage of adults over 65 years in the total population is rapidly increasing. The World Health Organization (WHO) estimates that by 2050, there will be approximately 2 billion elderly people living worldwide.

According to the WHO, osteoarthritis accounts for more than 50% of the musculoskeletal disease burden. In 2002, nearly 9.6% of the men, and 18% of the women above the age of 60 suffered from symptomatic osteoarthritis. Similarly, worldwide, there are a growing number of people suffering from back pain. The prevalence of back pain has been estimated to be the highest among middle age individuals ranging from 30 years to 50 years. The annual incidence of low back pain in the US and Europe has been found to be approximately 5% of the total population. 200 million people worldwide are at risk for a fragility fracture, and 40% of women and 14% of men older than 50 years will experience a fragility fracture. Many people who have had a fragility fracture will have another later in life. The number of patients who fracture their hip, a common form of fragility fracture, is expected to increase by 190% between 2000 and 2051.

A number of other factors are responsible for the growth in the incidence of musculoskeletal conditions. Urbanization and sedentary work have been linked with the rising incidence of back related problems. The lack of exercise and dietary changes are leading to a rise in the incidence of obesity, which is a major risk factor for the development of knee osteoarthritis and back pain. Smoking, to an extent, has also been associated with the loss of bone density, leading to an increased incidence of fractures.

These factors will result in a tremendous growth in the demand for orthopedic surgeries in the future.

Depuy, Inc. (Depuy), Stryker Corporation (Stryker), Zimmer Holdings, Inc. (Zimmer), Synthes, Inc. (Synthes), Smith & Nephew plc (Smith & Nephew), Medtronic, Inc. (Medtronic), and Biomet, Inc. (Biomet) were the leading companies in the global orthopedic implants market in 2008. The market is dominated by multinational players, accounting for about 80% of the total market. Depuy was the market leader and accounted for 17% of the market in 2008. Stryker, Zimmer, and Synthes, Medtronic, Smith & Nephew and Biomet accounted for 15%, 14%, 10%, and 8%, 7% and 7% respectively.

The global market for orthopedic implants is dominated by the presence of a few multinational players. The industry is seeing a number of diversification activities lately, where leading players are expanding their presence in high growth markets such as spine surgery.

Procedures and Techniques That Conserve Tissue, And Restore Natural Motion Gaining Favor among Young Patients

Novel technologies driven by the need for less trauma and greater motion restoration are contributing towards the growth of the overall orthopedics market. In joint replacement, partial joint replacement is witnessing the greatest adoption and acceptance amongst surgeons and patients. Partial replacement conserves more of the bone of patients, which facilitates fewer complications during revision surgeries. Procedures such as hip resurfacing and partial knee replacement are also better suited for young patients, where total joint replacement is not recommended. Thus, these procedures are driving demand in young adults in their 40s and 50s who currently have had to endure pain due to the lack of alternatives.

Minimally invasive surgeries have transformed orthopedic surgeries in a significant way. Not only do these procedures save costs, but they also provide considerable benefits such as faster recovery times and reduced pain to patients. Innovation in implants and the instrumentation required during the surgery are driving greater adoption of minimal invasive surgeries.

Greater durability of new implants, due to advances in materials and design, is also driving more surgeries among young patients. Earlier, due to the high incidence of wear and tear in young patients due to their higher activity levels, had led to deferment of surgeries in these patients. New implants now claim to last up to 25-30 years, which is enabling young patients to have the surgery earlier and live a pain free lifestyle.

About GBI Research

GBI Research is a leading business information company providing global business information reports and services.

Our highly qualified team of Analysts, Researchers, and Solution Consultants use proprietary data sources and various tools and techniques to gather, analyze and represent the latest and the most reliable information essential for businesses to sustain a competitive edge.